More about

Pancreatic Cancer

News
September 28, 2019
4 min read
Save

Surgical exploration ‘highly recommended’ after induction chemotherapy for locally advanced pancreatic cancer

BARCELONA, Spain — Four months of induction combination chemotherapy followed by surgical exploration made secondary resection feasible for about one-third of patients with nonresectable locally advanced pancreatic cancer, according to results of the randomized phase 2 NEOLAP trial presented at European Society for Medical Oncology Congress.

News
September 24, 2019
3 min read
Save

Neoadjuvant therapy may alter biliary microbiome in patients with pancreatic cancer

Neoadjuvant therapy may alter biliary microbiome in patients with pancreatic cancer

Patients with pancreatic cancer who received neoadjuvant therapy before pancreatoduodenectomy exhibited biliary microbiome alterations, according to study results.

News
September 04, 2019
2 min read
Save

Top stories in endocrinology: FDA fast tracks CKD drug, DPP-IV inhibitors may increase pancreatic cancer risk

Among the top stories in endocrinology last week were the FDA’s decision to fast track the sodium-glucose cotransporter 2 inhibitor dapagliflozin to delay renal failure in patients with or without diabetes who also have with chronic kidney disease and a study that found adults with type 2 diabetes treated with dipeptidyl-peptidase IV inhibitors were more likely to develop pancreatic cancer than those who received other treatment.

News
August 27, 2019
2 min read
Save

DPP-IV inhibitors may increase risk for pancreatic cancer

DPP-IV inhibitors may increase risk for pancreatic cancer

Adults with type 2 diabetes who are treated with DPP-IV inhibitors are more likely to develop pancreatitis and pancreatic cancer compared with those treated with other medications, according to findings published in Diabetes Care.

News
August 23, 2019
4 min read
Save

High-volume, NCI-designated centers not associated with greater value in pancreatic cancer care

High-value care appeared associated with important patient, tumor and treatment characteristics among patients with early-stage pancreatic cancer who underwent curative resection, according to results of a retrospective study published in JAMA Surgery.

News
August 22, 2019
2 min read
Save

Adavosertib regimen appears safe, shows promise for improving pancreatic cancer survival

Adavosertib regimen appears safe, shows promise for improving pancreatic cancer survival

The combination of adavosertib, gemcitabine and radiation appeared safe and potentially effective for patients with newly diagnosed, locally advanced pancreatic cancer, according to results of a phase 1 dose-escalation study published in Journal of Clinical Oncology.

News
August 10, 2019
1 min read
Save

NCI grant to fund research into aggressive pancreatic cancer subtype

NCI grant to fund research into aggressive pancreatic cancer subtype

Sita Kugel, PhD, a scientist at Fred Hutchinson Cancer Research Center, received an NCI award that will fund her laboratory’s research into an aggressive form of pancreatic cancer.

News
August 06, 2019
5 min read
Save

USPSTF upholds recommendation against screening for pancreatic cancer

USPSTF upholds recommendation against screening for pancreatic cancer

The U.S. Preventive Services Task Force reaffirmed its stance against pancreatic cancer screening for asymptomatic adults with no family history of the disease.

View more